REQUEST A DEMO
Total
USD $0.00
Search more companies

OU PharmaFourteen (Estonia)

Main Activities: Pharmacies and Drug Stores
Full name: OU PharmaFourteen Profile Updated: November 12, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

OU PharmaFourteen is a company in Estonia, with a head office in Tallinn. The enterprise currently operates in the Pharmacies and Drug Stores sector. The company was established on February 19, 2020. The total number of employees is currently 3 (2024). There was a net sales revenue drop of 2.04% reported in OU PharmaFourteen’s latest financial highlights for 2024. Over the same period, its total assets decreased by 19.17%. The net profit margin of OU PharmaFourteen increased by 0.26% in 2024.

Headquarters
Akadeemia tee 45 Mustamae linnaosa
Tallinn; Harju county; Postal Code: 13520

Contact Details: Purchase the OU PharmaFourteen report to view the information.

Basic Information
Total Employees:
Purchase the OU PharmaFourteen report to view the information.
Registered Capital:
Purchase the OU PharmaFourteen report to view the information.
Financial Auditors:
Purchase the OU PharmaFourteen report to view the information.
Incorporation Date:
February 19, 2020
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after OU PharmaFourteen report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-2.04%
Total operating revenue
-2.04%
Operating profit (EBIT)
562.2%
EBITDA
2.64%
Net Profit (Loss) for the Period
558.63%
Total assets
-19.17%
Total equity
6.29%
Operating Profit Margin (ROS)
0.27%
Net Profit Margin
0.26%
Return on Equity (ROE)
-5.76%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?